StreetInsider.com After-Hours Movers 01/03: (SHLM) (ROVI) (CYTK) Higher; (ARAY) (ITMN) (CSTR) Lower (more...)
Tweet
Share
E-mail
Get Alerts ARAY Hot Sheet
Join SI Premium – FREE
Accuray Incorporated (Nasdaq: ARAY) 20% LOWER; sees revenue of $72 million to $75 million, which is well below the consensus of $94.1 million. The company (1) manufacturing and supply related issues, which delayed contribution from new products launched at the 2012 Annual Meeting of the American Society for Radiation Oncology (ASTRO), and (2) commercial focus and salesforce transitional issues.
Cytokinetics, Incorporated (NASDAQ: CYTK) 13% HIGHER; new Overweight at Piper Jaffray
Schulman (NASDAQ: SHLM) 5% HIGHER; reported Q1 EPS of $0.50, $0.01 better than the analyst estimate of $0.49. Revenue for the quarter came in at $540.6 million versus the consensus estimate of $495.4 million. Schulman reaffirmed FY2013 guidance
Rovi Corporation (Nasdaq: ROVI) 4% HIGHER; intends to pursue the sale of its Rovi Entertainment Store business as part of its ongoing strategic efforts to focus the Company on growth opportunities related to its core enabling technologies and services. The Company has retained GCA Savvian Advisors, LLC as its financial adviser in connection with the potential sale. Boosts FY12 EPS outlook.
InterMune, Inc. (Nasdaq: ITMN) 4% LOWER; announced unaudited net sales of Esbriet (pirfenidone) for the fourth quarter ended December 31, 2012
Coinstar, Inc. (NASDAQ: CSTR) 3% LOWER; announcement that CEO Paul Davis will be stepping down in March. The company named CFO J. Scott Di Valerio as his successor.
Insulet Corporation (NASDAQ: PODD) 2% LOWER; announced the sale of $85 million of its common stock pursuant to an underwriting agreement with Canaccord Genuity Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) 13% HIGHER; new Overweight at Piper Jaffray
Schulman (NASDAQ: SHLM) 5% HIGHER; reported Q1 EPS of $0.50, $0.01 better than the analyst estimate of $0.49. Revenue for the quarter came in at $540.6 million versus the consensus estimate of $495.4 million. Schulman reaffirmed FY2013 guidance
Rovi Corporation (Nasdaq: ROVI) 4% HIGHER; intends to pursue the sale of its Rovi Entertainment Store business as part of its ongoing strategic efforts to focus the Company on growth opportunities related to its core enabling technologies and services. The Company has retained GCA Savvian Advisors, LLC as its financial adviser in connection with the potential sale. Boosts FY12 EPS outlook.
InterMune, Inc. (Nasdaq: ITMN) 4% LOWER; announced unaudited net sales of Esbriet (pirfenidone) for the fourth quarter ended December 31, 2012
Coinstar, Inc. (NASDAQ: CSTR) 3% LOWER; announcement that CEO Paul Davis will be stepping down in March. The company named CFO J. Scott Di Valerio as his successor.
Insulet Corporation (NASDAQ: PODD) 2% LOWER; announced the sale of $85 million of its common stock pursuant to an underwriting agreement with Canaccord Genuity Inc.
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Piper Jaffray, After-Hours Movers, Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
